B cell responses to a peptide epitope. VIII. Immune complex-mediated regulation of memory B cell generation within germinal centers by Nayak, Bishnu P. et al.
of May 26, 2011
This information is current as
 1999;163;1371-1381J Immunol
 
V. S. Rao
Bishnu P. Nayak, Anshu Agarwal, Pooja Nakra and Kanury
 
Centers
Memory B Cell Generation Within Germinal
Immune Complex-Mediated Regulation of 
B Cell Responses to a Peptide Epitope. VIII.
References
 http://www.jimmunol.org/content/163/3/1371.full.html#related-urls
Article cited in: 
 
 http://www.jimmunol.org/content/163/3/1371.full.html#ref-list-1
, 11 of which can be accessed free at:cites 44 articlesThis article 
Subscriptions
 http://www.jimmunol.org/subscriptions
 is online at The Journal of ImmunologyInformation about subscribing to 
Permissions
 http://www.aai.org/ji/copyright.html
Submit copyright permission requests at
Email Alerts
 http://www.jimmunol.org/etoc/subscriptions.shtml/
Receive free email-alerts when new articles cite this article. Sign up at 
Print ISSN: 0022-1767 Online ISSN: 1550-6606.
Immunologists, Inc. All rights reserved.
by The American Association ofCopyright ©1999 
9650 Rockville Pike, Bethesda, MD 20814-3994.
The American Association of Immunologists, Inc.,
 is published twice each month byThe Journal of Immunology
 o
n
 M
ay 26, 2011
w
w
w
.jimmunol.org
D
ow
nloaded from
 
B Cell Responses to a Peptide Epitope. VIII. Immune
Complex-Mediated Regulation of Memory B Cell Generation
Within Germinal Centers1
Bishnu P. Nayak, Anshu Agarwal, Pooja Nakra, and Kanury V. S. Rao2
Using an in vivo reconstitution assay, we examine here the role of immune complexes in both formation of germinal centers (GC)
and processes that occur subsequently within. The presence of Ag, as immune complexes, was found not to constitute a limiting
requirement for the initiation of GC formation. No detrimental effect either on numbers or sizes of the resulting GC was observed
when Ag-containing immune complexes were omitted during reconstitution. Thus, both recruitment and proliferation of Ag-
activated B cells within GC appear not to be limited by Ag concentrations. In contrast, the presence of immune complexes was
observed to be obligatory for the generation of Ag-specific memory B cells. This optimally required immune complexes to be
constituted by IgG-class Abs with epitope specificities that were homologous to those of the GC B cells. The GC reaction was also
found to be characterized by an enhancement of Ab specificity for the homologous epitope. Although some improvement in
specificity was noted in recall responses from immune complex-deficient GC, the presence of appropriate immune complexes
served to further optimize the outcome. Here again, isotype and epitope-specificity of the Ab constituent in immune complexes
proved to be important. The Journal of Immunology, 1999, 163: 1371–1381.
E xtensive studies over the last decade or so have unraveledmuch of the processes related to induction and maturationof T cell-dependent B cell responses. It is now clear that
the primary site of B cell activation is in the T cell-rich extrafol-
licular sites. Soon thereafter, foci of specific Ab-producing B cells
(AFCs)3 concentrate in the periphery, in the neighborhood of the
red pulp, of the periarteriolar lymphoid sheath (1). In the next few
days, germinal centers (GCs) can be observed to develop within
the primary B cell follicles, where processes related to affinity
maturation and B lymphocyte differentiation into either memory or
plasma cells are initiated (2–4).
Although the overall scheme has been documented with a va-
riety of Ag systems, there are several aspects that continue to re-
main enigmatic. One of these is the constituents that are required
to initiate a GC reaction. Early studies suggested that the formation
of GCs was facilitated by the trapping of immune complexes
within the network of follicular dendritic cells (FDCs) and B cells
in the lymphoid follicle (5, 6). Such an inference has been derived
from observations that immunization with Ag-specific immune
complexes, as opposed to Ag alone, results in a more rapid induc-
tion of GCs (7, 8). Interestingly, the rate of somatic mutation was
also found to be higher in such cases, resulting in secondary AFCs
secreting higher-affinity Ab when compared with those from mice
primed with Ag alone (7, 9). Finally, the rate of memory B cell
development was also enhanced in immune complex-immunized
mice, leading to increased anamnestic responses (7). However,
contrary to the inferences derived from such studies, there are
other reports in the literature that document that the appearance of
GCs precedes observation of detectable levels of FDC-bound im-
mune complexes (10). Although it is possible that these latter re-
sults simply reflect limitations in the sensitivity of detection of
immune complexes, nevertheless they suggest that deposition of at
least significant levels of immune complexes onto FDCs are not a
prerequisite to the initiation of GCs.
While the molecular regulators of somatic mutation within GCs
continue to be an area of active interest (11), resolution is also
awaited of the processes that occur subsequent to the generation of
B cells bearing mutated sIg variant receptors. It is generally ac-
cepted that somatic mutation within GCs is followed by positive
selection for those B cell variants with an increased affinity for Ag
(12–14). The drive for positive selection is thought to be centered
around Ag, which, in GCs, is available either in the form of FDC-
bound immune complexes or iccosomes (see Ref. 15). A variety of
mechanisms have been proposed to rationalize Ag access by GC B
cells, a critical determinant of positive selection. These include
competitive displacement of Ag from immune complexes (see Ref.
16), uptake as iccosomes (see Ref. 1), or proteolytic cleavage of
Ag-Fab complexes from FDC-bound immune complexes (17). An
interesting caveat has recently been provided by Manser and co-
workers (18). They have elegantly demonstrated that, although af-
finity maturation was operative, specificity proved to be the over-
riding consideration that guided positive selection (18). Thus in an
anti-arsenate response, GC B cells were found to be selected on the
basis of increased specificity for homologous Ag, thereby reducing
the probability of cross-reactivity with self-Ags (18).
From the discussion above, it is clear that there continue to
remain gaps in our knowledge of processes that govern induction
and maturation of T cell-dependent B cell responses. This is es-
pecially true of finer details of the GC reaction. In an earlier report,
we had demonstrated that the GC seeding competency of an Ag-
activated B cell is established early, soon after Ag exposure, and
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that it correlates with affinity for Ag (19). For these studies, we had
employed an in vivo GC reconstitution protocol that involved
adoptive transfer of Ag-primed B and T cells, along with appro-
priate immune complexes into irradiated mice. Using the same
protocol, we, in the present report, have examined the influence of
immune complexes on the GC reaction. We show that, although
nonlimiting for initiating a GC reaction, the presence of immune
complexes was nevertheless critical for the enhancement of Ag-
specific B cell memory. Further, this activity was restricted to only
those immune complexes in which the constituent Abs shared a
common epitope specificity with the GC B cells, with an optimum
requirement for IgG isotype of Abs. Finally, while enhancement of
Ab specificity within GCs was initiated in the absence of detect-
able levels of immune complexes, the presence of appropriate im-
mune complexes served to maximize the outcome.
Materials and Methods
Materials
HRP-labeled secondary Abs were obtained from Sigma (St. Louis, MO).
Coated magnetic beads for panning B and T cells (Dynabeads, Mouse pan
B and Mouse pan T) were purchased from Dynal (Oslo, Norway). Deri-
vatized amino acids for peptide synthesis were purchased from Novabio-
chem (Laufelfingen, Switzerland). Biotinylated peanut lectin agglutinin
(PNA), streptavidin-alkaline phosphatase, and streptavidin-HRP were ob-
tained from Vector Laboratories (Burlingame, CA), and anti-B7.2 (clone
GL1) was obtained from PharMingen (San Diego, CA). Noncleavable kits
for multiple peptide synthesis were purchased from Chiron Mimotopes
(Victoria, Australia).
Peptide synthesis
Peptides PS1CT3, CT3, and the Tyr33-substituted analogue of peptide
PS1CT3 were synthesized on a Milligen 9050 synthesizer (Millipore, Bed-
ford, MA) using F-moc chemistry (20). For peptide-specific staining of GC
B cells, the tetrameric, biotinylated peptide was also synthesized by the
F-moc chemistry, but using the strategy described earlier (19). Crude pep-
tides were purified to .95% purity by reverse phase HPLC on a C-18
column (15 mm; dPAK, Waters, Milford, MA; 19 3 300 mm) using an
aqueous gradient of 0–70% acetonitrile in 0.1% trifluoroacetic acid. The
identity of all peptides were ascertained both by amino acid analysis and
mass spectrometry.
Overlapping and analogue hexapeptide panels were synthesized by the
method of Geysen (21) on noncleavable multipin kits following the stan-
dard protocol recommended by the manufacturer. After completion of syn-
thesis, all peptides were routinely acetylated at the amino terminus with a
50/5/1 (v/v/v) mixture of dimethylformamide, acetic anhydride, and
triethylamine.
Radioiodination
Either 2 mg of peptide PS1CT3 or 1 mg each of mAbs PC287 and PC7bM
were iodinated with Na125I in the presence of Iodobeads (Pierce, Rockford,
IL) in 400 ml of 10 mM phosphate buffer, pH, 7.2. The reaction time was
10 min at 4°C. After this, the solution was collected and the free iodine
removed first by gel filtration followed by exhaustive dialysis against PBS.
Sp. act. of iodination was calculated from the known molecular mass of
peptide (4,029 Da) and taking an approximate molecular mass of 150,000
Da for the monomer Ig unit.
Animals and immunizations
Female BALB/c mice (6–8 wk old) were obtained from the small animal
breeding facility at the National Institute of Nutrition (Hyderabad, India).
Except where stated, primary immunizations were generally given i.p. at a
dose of 50 mg/mouse as an emulsion in CFA. For polyclonal sera, mice
were bled from the retroorbital plexus and, if necessary, sera within a group
pooled. For CT3 priming, mice were immunized with 50 mg/mouse of a
CFA emulsion of peptide CT3 (at base of tail) followed by a booster seven
days later. Lymph nodes were removed at 3 days (day 10) after the boost.
Ab preparations and generation of immune complexes
Primary anti-PS1CT3 antisera either from GL1-treated or untreated mice
was collected at day 7 after a primary immunization with peptide PS1CT3.
Normally derived secondary anti-PS1CT3 IgG was obtained as described
previously (22). Briefly, BALB/c mice were immunized with peptide
PS1CT3 as described above. Three weeks later, spleens were removed and
splenocytes transferred into irradiated (550 rad) hosts. This was followed
by a challenge with soluble peptide (50 mg/mouse in PBS, i.v.) 16 h later
(day 0), and sera was collected on day 5. Before analysis of polyclonal
preparations, sera were resolved for the IgG components by passing over
a protein G-Sepharose column (Pharmacia, Uppsala, Sweden). While the
flow-through consisted of IgM, bound Abs were eluted with glycine-HCl
buffer, pH 2.7. The eluate was immediately neutralized, concentrated, and
then dialyzed against PBS before use. Where necessary, IgG fractions were
further purified for peptide-specific Abs by incubating with a PS1CT3-
Sepharose affinity column (overnight at 4°C). After the requisite washes,
bound Ab was eluted in glycine-HCl buffer and processed as described
above.
Monoclonal Ab preparations used here have been described earlier (23)
and were obtained from hybridoma culture supernatants and concentrated
as required. For the preparation of immune complexes, either day 7 pri-
mary polyclonal anti-PS1CT3 IgG (from GL1-untreated mice) or the in-
dividual mAb preparations were incubated with a 10-fold molar excess
(based on the estimated number of specific binding sites) of peptide
PS1CT3 in PBS for 1 h at 37°C with occasional shaking. The preparation
was then dialyzed against PBS (three changes over 4 h) to remove unbound
peptide and concentrated if necessary. With all mAbs used, that saturated
immune complexes could be formed was first verified with the radioiodi-
nated analogue of peptide PS1CT3.
Enrichment of B and T cells from immunized mice and
reconstitution of GCs in vivo
Either splenocytes from PS1CT3-immunized mice (for B cells) or inguinal
lymph node cells from CT3-primed mice (for T cells) were first depleted of
RBCs followed by adherent cells as described earlier (19). For enriched B
cells, the corresponding splenocyte suspension was depleted of T cells by
two rounds of treatment with excess anti-Thy1.2-coated magnetic beads
(Dynal). On the other hand, for enriched T cells, lymph node cells were
similarly deprived of B cells by using anti-B220-coated magnetic beads
(Dynal). The cell purity thus obtained was between 90–95% as determined
by a FACS analysis.
For reconstitution of GCs, the protocol employed was described before
(19). Briefly, a total volume of 200 ml containing immune complexes of 1
mg Ab and 5 3 106 enriched T cells from CT3-immunized mice were
transferred (i.v.) into irradiated (550 rad) BALB/c mice. Twenty-four hours
later, these mice also received (i.v.) enriched B cells (1 3 107 in 200
ml/mouse) derived from splenocytes of mice immunized 2 days earlier with
peptide PS1CT3. For enumeration of GCs, spleens were removed 10 days
after B cell transfer and sections prepared for immunohistochemical de-
tection of Ag-specific GCs. For quantitation of memory responses, spleens
were removed 3 wk after B cell transfer, and the resulting splenocytes were
transferred into freshly irradiated (550 rad) recipients. Sixteen hours after
this transfer, the hosts were challenged with soluble peptide PS1CT3 (50
mg/mouse in PBS, i.v.). Blood was collected 5 days later, and the sera was
purified for the IgG fraction as described above.
Immunohistochemical staining of Ag-specific GCs
Immunohistochemical staining of Ag-specific GCs was performed as de-
scribed previously (19). Briefly, 6-mm thick sections of frozen spleens
were thaw mounted onto glass slides and fixed in ice-cold acetone. En-
dogenous peroxidase activity was quenched with 0.1% phenylhydrazine,
and sections were blocked for nonspecific binding with a 1:1 proportion of
a 3% BSA solution and mouse nonimmune serum. Slides were then incu-
bated for 90 min with 20 mg/ml of PNA-biotin in HEPES, pH 7.5, washed,
and then followed with a second incubation with streptavidin-HRP (5
mg/ml in PBS, 45 min). Both incubations were performed at 37°C. Staining
for Ag-specific B cells was performed with the tetrameric peptide Tet-PS1
(19) at a concentration of 50 mg/ml overnight at 4°C. After a wash, the
slides were then treated with the recommended concentration of strepta-
vidin-alkaline phosphate conjugate in PBS for 45 min at 37°C. Bound
conjugates were then visualized in a sequential manner. The HRP conju-
gate was first detected by color development with the AEC staining kit
(Vector Laboratories), where a red color for PNA1 cells was obtained.
Bound alkaline phosphatase was revealed with the blue staining kit (Vector
Laboratories), which detected the presence of Ag-specific cells as a blue
color.
ELISAs
ELISA assays for determination of PS1CT3-specific Ab levels were as
described earlier (22). Ab cross-reactivity with pin-bound hexapeptides
was also evaluated by ELISA. For this, the protocol recommended by the
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manufacturer was strictly followed. Primary Abs were diluted appropri-
ately in PBS containing 2% BSA, 0.1% Tween 29, and 0.1% sodium azide.
Pins were incubated in 200 ml each of the Ab solution at 4°C overnight
with gentle shaking. Subsequently, they were washed and subjected to a
second round of incubation with the appropriate dilution of HRP-labeled
goat anti-mouse IgG at room temperature for 1 h, again with gentle shak-
ing. The chromogen used for detecting bound Ab was 2,29-azino-bis-(3-
ethyl-benzthiazoline-6-sulfonic acid)diammonium, and the absorbance was
measured at 405 nm after subtracting the background at 490 nm.
Results
Ag-specific immune complexes do not constitute a limiting
requirement for the initiation of a GC reaction
The model Ag used for these experiments was a synthetic peptide
PS1CT3 (sequence: HQLDPAFGANSTNPDGGDIEKKIAKMEK
ASSVFNVVNS). This has previously been shown to represent a T
cell-dependent immunogen and is comprised of a well-character-
ized B (residues 1–15, segment PS1) and a T (residues 18–38,
segment CT3) cell epitope (23). Separating the B and T cell
epitopes is a spacer of two glycine residues (positions 16 and 17)
that was included for reasons described (24). We have earlier
shown that the murine IgM response to this peptide includes in-
dividual Ab specificities that collectively recognize the entire PS1
segment (23). However, subsequent class switch to IgG was found
to be restricted to only those Ab subsets directed against a tet-
rapeptide epitope between positions 4 and 7 (sequence: DPAF) of
the PS1 segment (23). This apparent monospecificity for the DPAF
epitope was also shown to be retained in the secondary response (23).
In an earlier study (19), we had demonstrated that primary GCs
could successfully be reconstituted in irradiated hosts upon co-
transfer of Ag-primed T cells and Ag-containing immune com-
plexes followed 24 h later by an additional transfer of enriched B
cells from mice primed 2 days earlier with Ag. Therefore, this
ability to regenerate GCs from its individual constituents provided
us with a system to examine some of the processes that have been
shown to occur during the GC reaction. In the present report, we
have focussed on both the relevance and regulatory influences of
Ag-constituted immune complexes.
Although Ag-comprised immune complexes represent a critical
constituent of GCs, there are contradictory reports in the literature
on whether they are obligatory for the initiation of a GC reaction.
Thus while early reports suggested that GC formation is facilitated
by the trapping of immune complexes within the FDC network (5,
6), Kroese et al. (10) have subsequently noted that the appearance
of GCs precedes observation of detectable levels of FDC-bound
immune complexes. Consequently, as a first step, we sought to
re-examine this issue by reconstituting Ag-specific GCs either in
the presence or absence of immune complexes containing Ag. The
procedure employed was identical with that described earlier (Ref.
19, see also Materials and Methods). Enriched T cells from mice
primed with a peptide representing the T cell epitope segment of
peptide PS1CT3 (peptide CT3) were transferred into freshly irra-
diated mice either in the presence or absence of immune com-
plexes between peptide PS1CT3 and the IgG fraction of primary
day 7 polyclonal anti-PS1CT3 antisera from BALB/c mice. These
irradiated hosts also received 24 h later enriched B cells from a
separate cohort of mice that had been primed 2 days earlier with
peptide PS1CT3. We have previously shown that, when immune
complexes were included, this protocol supports Ag-specific GC
formation and that it was completely dependent upon the presence
of both Ag-activated B and T cells (19). Further, the number of
specific GCs obtained were found to peak by day 10 following B
cell transfer, after which the numbers declined to reach undetect-
able levels between day 16 and 18 (19).
In the present experiment, spleens were removed from the hosts
at 10 days after B cell transfer, and the resulting sections were
stained for the detection and enumeration of Ag-specific GCs (Ma-
terials and Methods). Interestingly, the presence of Ag-specific
GCs could be detected even in mice not provided with immune
complexes during adoptive transfer (Fig. 1). Indeed, as shown
later, deprivation of externally supplied immune complexes had no
effect on the magnitude of the GC response either in terms of
number or size distribution.
It was possible that the GC response observed in the immune
complex-deprived group may have resulted from residual levels of
either free Ag or immune complexes occurring as contaminants in
the B cell preparation. To verify this, we synthesized an additional
analogue of peptide PS1CT3 where the Phe residue at position 33
was substituted with Tyr to permit labeling with radioactive iodine.
After first ascertaining that this Tyr substitution did not alter im-
munogenicity of the peptide (data not shown), we radioiodinated
the analogue peptide to a final sp. act. of 9.7 3 106 Ci/mmol.
Subsequently, individual BALB/c mice were immunized with the
FIGURE 1. Immunohistochemical staining for Ag-specific GCs reconstituted in vivo. GCs were reconstituted either in the presence or absence of day
7 polyclonal primary anti-PS1CT3 IgG as described in Materials and Methods. B, Representative staining of an Ag-specific GC in splenic sections of
irradiated hosts not provided with immune complexes is shown. The PNA1 B cells are seen as red, whereas Ag-specific staining appears as blue. A, A GC
devoid of Ag-specific B cells, obtained from splenic sections of a mouse mock-immunized with CFA is shown.
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radioactive peptide in a manner and dose identical with that em-
ployed for the parent peptide (Materials and Methods). Subse-
quently, enriched B cell preparations were derived from these mice
and quantitated for radioactivity present per 1 3 108 B cells as an
estimate of the level of contaminating peptide transferred during
reconstitutions. However, in such experiments, we were unable to
detect the presence of any radioactivity above background levels in
such preparations (data not shown). This was equally true of B cell
preparations derived from all the three mice that had been immu-
nized with labeled peptide. Thus, it would appear that the B cells
employed in GC reconstitution experiments were devoid of con-
tamination with at least detectable levels of peptide Ag. From the
sp. act. of the radiolabeled peptide, we estimate a lower reliable
limit of detection to be 5 fmol of peptide/107 B cells (based on a
cut off value of mean background cpm 1 5 SD).
To further probe whether immune complexes are required for
the initiation of a GC reaction, we also employed those constituted
with anti-PS1CT3 mAbs that had been raised earlier (23). Two
mAb preparations, mAb PC7bM and mAb PC287 (23), were ini-
tially employed. Although both mAbs have been shown to be di-
rected against the immunodominant DPAF epitope within
PS1CT3, mAb PC7bM was an IgM Ab, whereas PC287 was of the
IgG isotype (23). Peptide PS1CT3-specific GCs were reconstituted
in vivo either in the presence or absence of peptide containing
immune complexes of either of these two mAbs. At 10 days after
B cell transfer, spleens were removed for an analysis of the mag-
nitude of the peptide-specific GC response. To facilitate a com-
parison with the native situation, a parallel group of nonirradiated
BALB/c mice were immunized with peptide PS1CT3 and the GC
response was analyzed 10 days later. The results obtained from
such an experiment are presented in Table I. As is evident, the
magnitude of the GC response, both in terms of numbers and size
distribution, remained relatively invariant regardless of the pres-
ence or absence of externally supplied immune complexes (Table
I). Further, it was also independent of the isotype of mAb used for
the preparation of immune complexes. Finally, the magnitude of
the GC response in irradiated-reconstituted mice was comparable
to the primary GC response in healthy mice (Table I). Collectively,
therefore, the data in Table I seem to suggest that both recruitment
and proliferation of Ag-activated B cells was equally well facili-
tated under all of the variable conditions employed.
Although in our experiments with the radioactive peptide we
were unable to detect Ag contamination in the B cell preparation
used for adoptive transfer, the formal possibility of the presence of
Ag levels below detection limits cannot be definitively excluded.
Nevertheless, the cumulative data strongly suggests that the Ag
load within follicles does not constitute a limiting entity during GC
formation. In addition, the comparable magnitude of the GC re-
sponse obtained in irradiated-reconstituted mice and normal, im-
munized mice serves to further validate our reconstitution
protocol.
Immune complexes influence generation of Ag-specific B cell
memory
A critical end product of the GC reaction is the generation of
Ag-specific memory B cells. Although a variety of intercellular
interactions between GC B cells, T cells, and FDCs have been
implicated (1, 3, 17, 18), a direct role, if any, for Ag-containing
immune complexes remains to be clarified. To obtain preliminary
information on this, we sought to determine the extent of PS1CT3-
specific memory B cells produced in the various groups described
in Table I. To estimate memory B cell generation, we used the
protocol established by Zinkernagel and coworkers (25), where
splenocytes were transferred into freshly irradiated (550 rad) hosts
and followed by a challenge with soluble Ag several hours later.
Relative memory responses could then be quantitated as recall IgG
titers measured within a few days of antigenic challenge. Although
the early time point of measurement of recall IgG necessarily
yields low titer values, it was demonstrated that it, nevertheless,
accurately reflects differences in the frequency of responder cell
populations (25). More recently, we have also validated the appli-
cation of this procedure for the relative estimation of anti-PS1CT3
memory B cell responses (22).
Splenocytes from the various groups described in Table I were
collected at 21 days after B cell transfer and transferred again into
freshly irradiated hosts. Following this, anamnestic IgG titers were
determined at 5 days after antigenic challenge as described in Ma-
terials and Methods. The results thus obtained are depicted in Fig.
2. A dominant, albeit selective, influence of incorporated immune
complexes is clearly evident on the extent of Ag-specific B cell
memory that is produced (Fig. 2). While the magnitude of the GC
response was indistinguishable from the other groups, recall IgG
responses were barely detectable in splenocytes from immune
complex-deprived mice (Fig. 2). In contrast, significant recall IgG
levels were obtained from immune complex-supplemented mice,
although immune complex preparations with the IgG Ab proved
markedly more effective than those with the IgM mAb (Fig. 2).
Indeed, recall responses from mice provided with peptide-PC287
immune complexes were comparable with secondary responses
from healthy, nonirradiated mice immunized with peptide PS1CT3
(Fig. 2).
In addition to a quantitative parity, we also performed qualita-
tive comparisons between the latter two groups described above.
This was achieved by examining the relative avidity for peptide of
the two IgG preparations by competitive inhibition ELISA, and
also the kinetics of Ag binding in fluorescence quenching assays.
The data from both of these experiments are shown in Fig. 3,
where, as is evident, both preparations displayed similar Ag bind-
ing properties either in terms of avidity (Fig. 3A) or saturation rates
(Fig. 3B). Thus, in conjunction with our earlier described charac-
terizations, the data in Fig. 3 further substantiate that our recon-
stitution protocol generates GCs that are reminiscent of the native
situation, at least in the context of the present system.
However, it remained to be established that, when provided ex-
ternally, immune complexes do in fact localize within GCs. For
this we employed immune complexes where either peptide or mAb
was radioiodinated. A knowledge of the sp. act. of the radiolabeled
Table I. The magnitude of a GC response is immune complex
independenta
Group GCs/10 Sections
Size
Small Medium Large
1 25 6 6 8 78 14
2 26 6 4 6 80 14
3 23 6 5 10 75 15
4 32 6 7 8 76 16
a As described in Materials and Methods, PS1CT3-specific GCs were reconsti-
tuted either in the absence (group 1) or presence of immune complexes generated with
the mAbs PC7bM (group 2) or PC287 (group 3). Group 4 represents normal, nonir-
radiated mice that were immunized with peptide PS1CT3. Ten days after B cell
transfer (or after immunization for group 4), the mice were sacrificed and GCs enu-
merated in spleen sections. At least 30 dispersed sections were analyzed per spleen.
GC numbers are presented as an average (6 SD) over 10 sections for five mice per
group. For size distribution, a minimum of 50 peptide-specific GCs per group were
analyzed for size and scored as either small, medium, or large on the basis of width
in the largest dimension of ,25, between 25–50, and .50 PNA1 cell diameter,
respectively. These data are presented as a percent of the total number of GCs ex-
amined per group.
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constituents was also expected to permit estimation of the immune
complexes actually resident within the GCs. Peptide PS1CT3-spe-
cific GCs were reconstituted in irradiated hosts either in the ab-
sence or presence radioactive immune complexes between the pep-
tide and either mAb PC7bM or mAb PC287. Subsequently derived
splenic sections were immunohistochemically stained for detection
of Ag-specific GCs before their excision and determination of ra-
dioactive content. The results from such an experiment are shown
in Table II. As is evident, at least some of the externally provided
immune complexes do localize within Ag-specific GCs. Further,
the extent of localization appears to be comparable regardless of
whether the immune complexes contained the IgM or IgG isotype
of Ab. Finally, the stoicchiometry of peptide to Ig monomer ob-
tained was close to the theoretically expected value of 2:1
(Table II).
Another notional possibility that could account for the results in
Fig. 3 is that Ag dissociating from the provided immune com-
plexes could be captured by Abs being secreted by the activated B
cells in the transferred population. To rule this out, we also exam-
ined the serum half-life of the radiolabeled peptide in irradiated
BALB/c mice. Mice were immunized (i.v.) with 2.5 nmol of ra-
diolabeled peptide and then periodically bled for the determination
of radioactivity. These experiments yielded a short serum half-life
for peptide of ,4 h (data not shown). Thus, given the conditions
of our protocol where limiting amounts of Ag (;14 pmol/mouse)
in the form of immune complexes were given and that B cells were
introduced 24 h after injection of immune complexes, the possi-
bility of significant amounts of peptide exchange appears near neg-
ligible. This is further supported by the data in Table II where the
stoicchiometry of peptide to mAb within GCs was close to the
expected value. Finally, injection of either soluble peptide (250
pmol/mouse) instead of preformed immune complexes, or immune
complexes of peptide with the Fab of mAb PC287 also did not lead
to any enhanced memory generation (data not shown).
Thus, in light of the observations above, we interpret the data in
Fig. 2 to suggest that, within GCs, immune complexes regulate the
extent of Ag-specific memory B cells that are produced. Further,
this regulation is also modulated by the isotype of Abs that con-
stitute the GC resident immune complexes.
To establish that the findings reported above were not restricted
to peptide PS1CT3 but, rather, represents a general property of
immune complexes in GCs, we chose two additional, well-char-
acterized protein Ags hen egg lysozyme (HEL) and OVA. Irradi-
ated hosts were reconstituted with Ag (i.e., either HEL or OVA)-
primed T and B cells as earlier described either with or without
appropriate immune complexes produced from day 7 primary
polyclonal IgG. Anamnestic responses were subsequently deter-
mined and the results are presented in Fig. 4. It is unequivocally
clear for both Ags that, while significant levels of memory IgG was
FIGURE 2. Immune complexes regulate production of Ag-specific
memory B cells. GCs were reconstituted in irradiated mice from PS1CT3-
primed B and CT3-primed T cells as described in Materials and Methods.
Three weeks after B cell transfer, spleens were removed and the resulting
splenocytes transferred into freshly irradiated hosts. These mice were sub-
sequently challenged with soluble peptide, and the resulting anamnestic
responses quantitated as peptide PS1CT3-specific titers as described in
Materials and Methods. For normally derived secondary anti-PS1CT3 re-
sponses, BALB/c mice were immunized with a single dose of peptide
PS1CT3. Twenty-one days later, the splenocytes were removed, transferred
into irradiated recipients, and recall responses determined as described
above. The x-axis identifies individual groups in terms of the immune
complex that was provided. Data from individual mice are shown and are
from one of four separate experiments.
FIGURE 3. Recall anti-PS1CT3 IgG from reconstituted GCs are com-
parable to normally derived secondary anti-PS1CT3 responses. Purified
IgG fractions of recall responses from reconstituted GCs supplemented
with mAb PC287-peptide PS1CT3 immune complexes (E) and normally
derived secondary anti-PS1CT3 IgG (F) from Fig. 2 were compared for
their relative avidities for peptide by competitive inhibition ELISA (A). In
addition, these fractions were also purified for peptide-specific IgG over a
peptide-affinity column for a measurement of Ag binding rates (B). For
this, the preparations were diluted in PBS to a final concentration of 200
nM, to which was added 20 ml of PBS containing a 10-fold molar excess
(based on estimated binding sites assuming bivalency per IgG molecule) of
peptide PS1CT3. The resultant binding interaction, under pseudo-first or-
der conditions, was monitored as time-dependent quenching of tryptophan
fluorescence in a Shimadzu RF-1501 spectrofluorometer (Shimadzu Cor-
poration, Tokyo, Japan) until saturation was achieved. Excitation was at
280 nm and emission was recorded at 335 nm. Data shows the extent of
saturation as a function of time. Data in both panels are from one of two
independent experiments.
Table II. Radiolabeled immune complexes localize within GCsa
Immune Complex
Constituent (in fmol)/20 mm Section
Peptide mAb
PS1CT3-PC287 5.1 6 1.3 3.3 6 0.9
PS1CT3-PC7bM 3.9 6 1.1 2.3 6 0.7
a PS1CT3-specific GCs were reconstituted in irradiated hosts either in the pres-
ence or absence of immune complexes between peptide PS1CT3 and anti-PS1CT3
mAbs as described in Materials and Methods. Here, either radiolabeled peptide or
radiolabeled mAb was used, and the two mAbs employed were PC7bM and PC287.
At 7 days after B cell transfer, spleens were removed and 20-mm sections were
obtained for the immunohistochemical localization of GCs as described for Fig. 1.
These GCs were excised as previously described (45) and pooled in groups of be-
tween 10 and 20 for determination of incorporated radioactivity. Values given are the
mean obtained for three individual mice within each group, where a minimum of three
pools were measured. Molar quantities were calculated from the known specific ac-
tivity of iodination of the individual components which were as follows: PS1CT3,
9.7 3 106 Ci/mmol; mAb PC287, 6.1 3 108 Ci/mmol; mAb PC7bM, 3.2 3 108
Ci/mmol of monomer. For the IgM mAb PC7bM, molar estimates were calculated on
the basis of a monomeric unit.
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obtained from immune complex-supplemented GCs, this was only
marginal when immune complexes were excluded.
Regulation of memory B cell generation by immune complexes
is specificity-restricted
Our observations that generation of memory B cell responses is
dependent upon the presence of immune complexes within GCs
raised the intriguing question of whether the epitope fine-specific-
ity of the constituent Abs has any regulatory influence. To examine
this, we used additional anti-PS1CT3 mAbs, but directed against
alternate determinants within the PS1 segment of peptide PS1CT3.
Although, as depicted in Fig. 2, immune complexes with IgG class
Abs proved superior in eliciting a memory response, we have
shown earlier that the anti-PS1CT3 IgG response in BALB/c mice
is exclusively directed at the DPAF epitope (23). This was also
reflected at the level of mAbs that were obtained (23). In contrast,
the early primary anti-PS1CT3 IgM response was shown to consist
of heterogeneous epitope specificities where it was possible to ob-
tain a variety of mAbs directed against a variety of determinants
within the PS1 sequence (23). Consequently, for the purposes of
the present study, we were limited to the use of anti-PS1CT3
IgM mAbs.
The IgM mAbs used have been described earlier, and their prop-
erties are summarized in Table III. Immune complexes were pre-
pared between peptide PS1CT3 and each of these mAbs and sub-
sequently employed during in vivo GC reconstitution experiments.
Anamnestic IgG responses that resulted from each of these groups
were quantitated, and the results are given in Fig. 5. The notable
feature of the data shown is that the quantum of PS1CT3-specific
B cell memory generated was strictly dependent upon the epitope
fine-specificity of the mAb that constituted the immune complex
(Fig. 5). Thus, while immune complexes generated with DPAF-
specific mAbs were relatively potent at inducing a recall response,
those comprised by Abs directed against alternate determinants
were only marginally stimulatory (Fig. 5).
To understand the basis of the preference for immune com-
plexes composed of Abs of a unique specificity, we next analyzed
the distribution of epitope specificities within the anti-PS1CT3 IgG
recall responses in all the groups described in Fig. 5. For this,
purified IgG fractions were screened for cross-reactivity against a
panel of overlapping, single residue displaced hexapeptides that
collectively spanned the PS1 segment of peptide PS1CT3. For
comparative purposes, secondary IgG from normal PS1CT3-im-
munized mice was also included. Although results for only repre-
sentative groups are shown in Fig. 6A, all sera tested yielded a
unique reactivity profile restricted to three overlapping hexapep-
tides of sequence QLDPAF, LDPAFG, and DPAFGA. This, as we
have proved earlier (23) is indicative of monospecificty for the
DPAF epitope. Thus, the data in Fig. 6A reveal that, regardless of
quantitative differences among the groups, epitope specificity of
the recall IgG response remained invariant and directed against the
DPAF epitope. It may be noted from Fig. 6A that the normally
derived secondary IgG from nonirradiated mice also displays
DPAF monospecificity. In addition to the results described here,
we found that the recall responses from reconstituted GCs supple-
mented with mAb PC287-peptide immune complexes also dis-
played, as might be expected, DPAF monospecificity in epitope
mapping studies (data not shown).
Selection for DPAF monospecificity precedes the onset of a GC
reaction
In a previous report, we had demonstrated that the early primary
murine IgM response to peptide PS1CT3 was comprised of distinct
FIGURE 4. Immune complexes also enhance memory B cell generation
against representative protein Ags. Irradiated mice were reconstituted with
enriched B and enriched T cells from either HEL (A)- or OVA (B)-immu-
nized mice, either with (group 2) or without (group 1) appropriate immune
complexes generated with day 7 primary polyclonal antisera. Subsequent
recall responses were generated and quantitated as described for Fig. 2A.
Data from individual mice are shown.
Table III. Binding characteristics of anti-PS1CT3 IgM mAbsa
IgM mAb IC50 for Peptide (mM) Epitope Specificity
PC7bM 21.0 DPAF
PC7cM 4.0 DPAF
PC42M 1.5 NSTN
PC8aM 10.0 NSTN
PC6aM 32.0 FG
a The mAbs listed here are specific for the PS1 segment of peptide PS1CT3 and,
as previously described (23), were obtained from a fusion with splenocytes from a
mouse that had been immunized 4 days earlier with peptide PS1CT3. While their
epitope specificities have been characterized earlier (23), relative affinities for peptide
PS1CT3 were determined by competitive inhibition ELISA. IC50 values given are the
mean of two independent measurements.
FIGURE 5. The memory enhancement activity of immune complexes is
specificity restricted. Immune complexes were prepared between peptide
PS1CT3 and each of the anti-peptide IgM mAbs listed in Table III. These
were then independently included in PS1CT3-specific GC reconstitution
protocols, followed by elicitation and estimation of recall IgG levels as
described for Fig. 2. A control group was also included where immune
complexes were omitted during the cell transfer. Data are from individual
mice within each group and are representative of two independent
experiments.
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epitope specificities (23). Interestingly, however, a subsequent
class switch to the IgG isotype was accompanied by a stringent and
exclusive selection for the anti-DPAF subset (23). Such DPAF
monospecificity was also demonstrated to be retained in the sec-
ondary response (23). To verify the stage at which selection for
DPAF monospecificity occurs, we examined sera from PS1CT3-
immunized mice where GC formation had been inhibited by treat-
ment with the anti-B7.2 mAb, GL1. Consistent with earlier reports
(26), we have shown that multiple high-dose injections of GL1
also abrogates GC formation in PS1CT3-immunized mice, al-
though the primary humoral response was only marginally affected
(19). Both IgM and IgG fractions of day 7 sera from such mice
were analyzed for distribution of epitope specificities by screening
against the hexapeptide panel described in Fig. 6A. In these stud-
ies, the IgM anti-PS1CT3 response was found to retain the mul-
tispecific character described earlier for that from mice not treated
with GL1 (not shown, but see Ref. 23). In contrast, the early IgG
response displayed monospecificity for the DPAF epitope (Fig.
6B). This reactivity profile was identical with that described for
both primary and secondary IgG from GL1-untreated mice (23).
That dominant selection for the DPAF epitope occurs even in
the absence of any detectable GC formation strongly suggests that
this event precedes GC formation. Presumably then, it is this se-
lected subset that populates GCs. As a result, the requirement for
immune complexes constituted by DPAF-specific Abs noted in
Fig. 5 probably follows as a natural outcome of this selection.
To further verify the existence of specificity-restricted memory
enhancement, we also selected, as an additional model immuno-
gen, a hapten-carrier system, DNP-BSA, for study. Mice immu-
nized with DNP-BSA were bled 7 days later and the sera purified
over an affinity column for the DNP-specific and BSA-specific IgG
subpopulations. Subsequently, immune complexes were generated
between either of these fractions and DNP-BSA before utilization
in GC reconstitution protocols with Ag-primed T and B cells. Both
the resulting anti-DNP or anti-BSA anamnestic IgG responses
were then determined, and the results are presented in Fig. 7. It is
obvious from Fig. 7 that incorporation of immune complexes pre-
pared from anti-DNP IgG results in specific enhancement of anti-
DNP memory responses, but not that against the carrier BSA. On
the other hand, the reverse was true when immune complexes with
anti-BSA Abs were incorporated instead.
Thus, collectively the data in Figs. 5–7 clearly suggest that the
B cell memory enhancement activity of immune complexes within
GCs is epitope restricted by the epitope specificity of the Abs
constituting the immune complexes.
FIGURE 6. Epitope-specificity of recall (A) and early primary (B) anti-
PS1CT3 IgG responses. Purified IgG fractions from recall antisera derived
from the experiment in Fig. 5 were pooled within a group and screened for
cross-reactivity against the overlapping PS1-derived hexapeptide panel as
previously described by ELISA (Ref. 23, see also Materials and Methods).
The x-axis identifies each hexapeptide as its amino-terminal residue. Back-
ground reactivity, which was subtracted, was determined by simulta-
neously evaluating cross-reactivity of each preparation with that against an
irrelevant peptide of sequence AQGNSM. Data shown are from one of
three experiments. Although all sera tested from Fig. 5 gave essentially
identical profiles, only representatives are shown in A. These indicate
groups where immune complexes were constituted with the following
mAbs: a, no immune complex; b, mAb PC42 M; c, mAb PC7bM. For
comparative purposes, the profile obtained for normally derived secondary
IgG is also shown (d). B gives the results for day 7 IgG from PS1CT3-
immunized mice that had also been simultaneously treated with mAb GL1
to inhibit GC formation (see Results).
FIGURE 7. Specificity-restricted memory enhancement activity of im-
mune complexes is also revealed with a hapten-carrier system. Initially, a
large group of BALB/c mice were immunized with DNP-BSA (100 mg/
mouse in CFA, i.p.) to obtain day 7 antisera. After resolution of the IgG
fraction, a part of this preparation was passed over an affinity column
coupled to DNP-keyhole limpet hemocyanin to separate the DNP-specific
and BSA-specific IgG subsets. Subsequently, immune complexes with
DNP-BSA were prepared with either anti-DNP IgG (group 1), anti-BSA
IgG (group 2), or the total unfractionated IgG (group 3) and independently
included during reconstitution of GCs with DNP-BSA-primed T and B
cells as described in Materials and Methods. A separate control group was
also included where no immune complexes were provided (group 4).
Splenocytes from these hosts were then transferred, 21 days later, into
freshly irradiated recipients and recall responses elicited by challenge with
soluble DNP-BSA. DNP-specific IgG titers (A) were estimated by ELISA
against DNP-Ficoll as coat Ag, whereas BSA-specific titers (B) were de-
termined against native BSA. Values are mean titers (6SE) obtained from
three individual mice within each group and the data represent one of two
separate experiments.
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Immune complexes optimize but do not drive specificity
acquisition within GCs
Although several studies have documented that GCs also represent
the sites where affinity maturation of Abs occurs (reviewed in
Refs. 27–29), we have shown previously that progression of a
murine primary humoral response to peptide PS1CT3 is not char-
acterized by an increase in Ab affinity (19, 30). As a result, the
present system did not permit an analysis of the role of Ag-con-
taining immune complexes in affinity maturation. However,
Manser and coworkers have recently demonstrated that improve-
ment in Ag-specificity of Ab is yet another hallmark of the GC
reaction (18). Such a “specificity maturation” was postulated to be
critical in ensuring memory responses with little to no cross-reac-
tivity with self-Ags (18).
To evaluate for specificity maturation in the present system, we
took advantage of the fact that both primary anti-PS1CT3 IgG
from GL1-treated mice and recall IgG from GCs reconstituted un-
der various conditions were exclusively directed against the DPAF
epitope within PS1CT3. Therefore, we synthesized analogues of a
hexapeptide representing residues 3–8 (sequence: LDPAFG) of
peptide PS1CT3. In these analogues, individual residues within the
DPAF epitope (D, A, and F) were variably substituted with alter-
nate, chemically similar amino acid residues to generate a panel of
analogue sequences. This panel was then used to screen for Ab
cross-reactivity with recall IgG produced under the influence of a
representative set of immune complexes. For a comparison with
the specificity of anti-DPAF IgG before the onset of the GC reac-
tion, the IgG fraction of sera from GL1-treated mice was also
analyzed. Further, secondary IgG obtained under normal condi-
tions from nonirradiated mice was included as a qualitative refer-
ence for the expected end product of a GC reaction.
Results obtained from the experiment described above are
shown in Table IV. Primary anti-PS1CT3 IgG from GL1-treated
mice displayed poor specificity where several of the analogues
proved more reactive than the parent peptide (Table IV). In con-
trast, normally derived secondary responses were markedly more
Ag-specific, at least in the context of the panel tested (Table IV).
These results clearly point to the fact that an improvement in Ab
specificity is also a characteristic of murine humoral responses to
peptide PS1CT3. Notably, some enhancement of Ab specificity
could also be noted for recall IgG obtained from immune complex-
deprived GCs (Table IV). Supplementation of GCs with immune
complexes derived from non-DPAF-directed mAbs had no addi-
tional effect (Table IV). On the other hand, GCs containing im-
mune complexes prepared from DPAF-specific mAbs yielded a
marked improvement in Ab specificity, with again a greater effi-
cacy for immune complexes generated from IgG mAb as opposed
to IgM (Table IV). Indeed, the cross-reactivity profile for recall
IgG from GCs supplemented with PC287-constituted immune
complexes was almost identical with that obtained for normally
derived secondary anti-PS1CT3 IgG (Table IV). Thus, it appears
that, although an enhancement of epitope-specificity of Ab can
occur in their absence, the presence of immune complexes consti-
tuted by Abs of the appropriate specificity and isotype is necessary
to optimize the outcome.
Discussion
Germinal centers represent histologically defined structures that
support maturation and differentiation of Ag-activated B cells,
principally in T cell-dependent humoral responses. A prerequisite
to GC formation is the migration of Ag-activated B cells into
splenic follicles, which, in turn, appears to be regulated by a va-
riety of factors (31) that include an endogenous transcription ma-
chinery (32) and the presence of appropriate chemokine receptors
on the cell surface (33). Subsequent to this, B cells undergo rapid
proliferation, creating a secondary follicle, which then differenti-
ates into a GC with defined light and dark zones (34, 35). It is
within this complex microenvironment where somatic mutation is
Table IV. Specificity maturation is enhanced by the presence of appropriate immune complexesa
Analog Peptide
Relative Reactivity for Ab
Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
LEPGWG 111 1/– 1 1 – –
LDPSFG 1 – – – – –
LEPSYG – – – – – –
LDPGWG 11111 1 11 1 – –
LEPCYG 11 1 1 1 – –
LEPSFG – – – – – –
LEPALG – – – – – –
LEPCLG – – – – – –
LEPSLG – – – – – –
LDPAWG 11 1 1 1 1/– 1/–
LDPAYG – – – – – –
LEPAYG – – – – – –
LEPAWG 11 1/– 1/– 1/– – –
LDPLFG 1111 1 1 1 – –
LDPCWG 111 11 11 11 1/– –
LEPLFG 1 – – – – –
LDPALG – – – – – –
LDPAVG – – – – – –
LEPALG – – – – – –
LEPAIG – – – – – –
a Purified IgG fractions from either primary or recall anti-PS1CT3 responses were screened for cross-reactivity against analogs of the PS1-derived hexapeptide LDPAFG (see
text). For subtraction of background a nonspecific hexapeptide of sequence LVIMSG was used. Taking the reactivity of a given preparation with the parent peptide as 100%,
relative reactivity with individual analogs was scored as follows; ,25%, –; 25–50%, 1/–; 50–100%, 1; 100–200%, 11, 200–300%, 111; 300–400%, 1111; .400%,
11111. Group 1 represents the IgG fraction of primary anti-PS1CT3 antisera from GL1-treated mice. Group 6 identifies normally derived secondary IgG obtained as described
in Fig. 2. The remaining groups represent recall IgG from reconstituted GCs and differed in terms of the immune complex provided during GC reconstitution. These are as follows:
group 2, no immune complex provided; group 3, peptide-mAb PC42M; group 4, peptide-mAb PC7bM; group 5, peptide-mAb PC287. Data presented is that from one of two
independent experiments.
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initiated, followed by selection of a significant frequency of mu-
tated clonotypes into the memory compartment (27, 36).
Although there have been earlier suggestions that prior deposi-
tion of Ag-containing immune complexes onto the FDC network
within the primary follicle is also required to initiate a GC reaction,
our own results presented here indicates that this does not consti-
tute a limiting requirement. Adoptive transfer of only Ag-primed T
and B cells, in the absence of any added immune complex, was
sufficient to generate GCs in irradiated recipients. While we cannot
definitively rule out the possibility that trace, undetectable amounts
of either immune complexes or free Ag molecules were cotrans-
ferred with B cells, we note that the magnitude of the GC response
in this group, both in terms of number and size distribution, was
indistinguishable from those in groups provided with immune
complexes. These observations suggest that both recruitment and
proliferation of B cells within GCs are independent of the presence
of at least significant levels of immune complexes. Such an infer-
ence would also be consistent with the findings of Kroese et al.
(10). They had earlier demonstrated, using lethally irradiated and
reconstituted rats, that the development of GCs precedes detection
of FDC-bound immune complexes. However, the issue of whether
kinetics of GC formation is influenced by immune complexes, a
possibility that has been suggested earlier (37), was not addressed
in this study.
While the initiation of a GC reaction was found not to require
the prior presence of significant amounts of Ag in the form of
immune complexes, subsequent generation of memory B cells was
strictly immune complex dependent. Moreover, for peptide
PS1CT3, the memory-enhancement activity was restricted to im-
mune complexes constituted by Abs specific for the DPAF epitope
and with an optimal requirement for IgG as opposed to the IgM
isotype. In previous studies, we have shown that the early primary
anti-PS1CT3 humoral response is comprised of a heterogeneous
distribution of Ab fine-specificities that collectively span the entire
PS1 sequence (23). However, subsequent class switch and matu-
ration was restricted to only that subset of Ag-activated B cells that
were directed against the DPAF epitope (23). Here, by employing
the monoclonal anti-B7.2 Ab GL1 to inhibit GC development, we
have extended these results to indicate that selection for DPAF
monospecificity precedes initiation of the GC reaction. Therefore,
it follows that seeding of GCs would also be expected to be re-
stricted to this positively selected subset of anti-DPAF B cells.
Such an inference is entirely in keeping with our findings that
memory responses were invariantly DPAF-monospecific regard-
less of the nature of immune complexes employed in GC recon-
stitution. This was also the case when immune complexes were
excluded. Consequently, the observed specificity-restricted mem-
ory enhancement activity of immune complexes strongly suggests
that this is facilitated only when GC B cells encounter immune
complexes constituted by Abs with an identical fine specificity for
epitope. Such an inference was also supported by our results with
DNP-BSA where, again, selective amplification of memory B cells
with epitope specificities that were homologous to that of the Ab
constituent in the provided immune complexes was observed. Fur-
ther, the fact that the mAbs PC7bM and PC7cM Abs, whose de-
rivatives are absent from the anti-PS1CT3 IgG repertoire (30), also
displayed memory enhancement ability indicates that it is identity
at the level of epitope specificity rather than clonality that domi-
nates as the selection criterion.
Although our data implicate a role for immune complexes in
determining the quantum of B cell memory that is generated in the
course of a GC reaction, the precise stage at which this operates
remains to be defined. It is possible that immune complexes func-
tion by increasing the repertoire of GC B cells that are inducted
into the memory differentiation pathway. In this connection, Cerny
and coworkers have recently proposed that immune complexes in
GCs lower the threshold of B cell activation (37). The rationale for
such a proposal was based on the earlier demonstration that cova-
lent binding of the complement protein C3 to Ig in immune com-
plexes constitutes by being able to bridge B cell Ag receptor with
the CD21/CD19/CD81 complex, a potent stimulatory signal for B
cells (38). In this connection, it may be noted that complement
receptors, expressed on the surface of FDCs, appear to play an
important role in follicular trapping of immune complexes (1, 18,
39). While the majority of mAbs used in this study were of the IgM
isotype, the only exception, mAb PC287, was of the IgG1 subclass
(19). However, because the complement fixing abilities of these
mAbs was not examined, we cannot presently confirm whether
such a mechanism was indeed operative for the test system
employed here.
An alternate explanation for the memory enhancement activity
could derive from the possibility that immune complexes simply
promote proliferative expansion of already differentiated memory
B cells. A comparison of the memory B cell repertoires generated
from GCs prepared in the absence or presence of the various im-
mune complexes described here can be expected to shed some
light in this regard. Nevertheless, it is also interesting to note that
the magnitude of a GC response appears to have no direct bearing
on the extent of Ag-specific B cell memory that is eventually pro-
duced. Thus, while the resulting anamnestic responses differed
greatly depending upon the inclusion or exclusion of relevant im-
mune complexes, the magnitude of the GC response was relatively
invariant.
One factor that could potentially have interfered with our results
was the possible presence of pre-existing natural anti-PS1CT3 Ab
in irradiated recipients. However, we have earlier been unable to
detect the presence of naturally occurring anti-PS1CT3 responses
either at the level of serum Ig or Ab-producing B cells (19, 40).
Further, injection of soluble peptide, along with the T cell fraction,
also did not result in the generation of PS1CT3-specific B cell
memory. In the event that functionally relevant natural Abs to
peptide were existent, soluble peptide immunization would be ex-
pected to generate immune complexes in vivo, with the consequent
promotion of memory responses. Finally, transfer of sera from
nonimmune irradiated mice, either with or without a prior incuba-
tion with peptide PS1CT3, along with the T cell fraction also did
not lead to any enhancement in subsequently evaluated memory
responses (B.P.N., unpublished observations). Thus, these results
collectively rule out a complicating role for naturally occurring
serum Ig in irradiated recipients.
The process by which GC B cells acquire Ag from immune
complexes is also an issue that remains to be examined. This is
equally true of both events, leading to positive selection of mutated
B cells and enhancement of the memory pool. However, several
alternate mechanisms have been put forward in the literature. For
example, it has been suggested that Ag capture by GC B cells
could be mediated by competitive displacement from immune
complexes presented either on intact FDCs or on the surface of
iccosomes (e.g., see Ref. 16). Indeed, in support of such a possi-
bility, our own recent results indicate that the memory enhance-
ment activity of immune complexes is dependent on the ability of
Ag to dissociate from the Ab (B.P.N., P.N., and K.V.S.R., manu-
script in preparation). Thus, for example, an immune complex
where peptide PS1CT3 was chemically cross-linked to mAb
PC287 was unable to induce amplification of PS1CT3-specific
memory B cell responses from reconstituted GCs (B.P.N., P.N.,
and K.V.S.R., manuscript in preparation). Nevertheless, an alter-
nate mechanism may also lie in the direct endocytic uptake of
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iccosomes by B cells, followed by Ag processing and presentation
(e.g., see Ref. 1). Finally, Leanderson and colleagues have envi-
sioned positive selection within GCs to occur by the direct binding
of B cells to Ag within immune complexes (17). Subsequent re-
lease of such bound B cells has been proposed to be mediated by
proteolytic cleavage of surface Ig (17). In principle, any of the
above mechanisms could explain positive selection of mutated GC
B cells, particularly under conditions where the Ag supply is lim-
iting. However our results, which reveal the importance of epitope-
specificity of Abs constituting the immune complexes, suggests
that the latter two mechanisms are unlikely to account for at least
the memory enhancement activity of immune complexes within
GCs. It is difficult to envisage specificity-restriction to be operative
in the context of Ag nonspecific uptake of iccosomes by endocy-
tosis. Further, the observed requirement of homologous epitope
specificities between the responder GC B cells and the Ab con-
stituent of immune complexes also suggests that such B cells
would be unable to directly bind immune complexes as the rele-
vant epitope is expected to be masked by Ab binding. However,
any definitive conclusion must await further analysis.
Our data also lend support to the notion of “specificity matura-
tion” within GCs as proposed earlier by Manser and coworkers
(18). Interestingly though, detectable levels of Ag supply in the
form of immune complexes again appeared to be redundant for
initiating this process. However, immune complexes of the appro-
priate specificity and isotype of Ab were required for further op-
timizing Ab specificity. These observations raise the possibility
that enhancement of Ab specificity within GCs may occur in two
stages: an Ag-independent step followed by an Ag-dependent one.
Although this proposal remains to be verified, it is likely that the
Ag-independent stage correlates with the recent demonstrations
that engagement of GC B cells by soluble Ag (and, therefore, also
cross-reactive self-Ags) leads to apoptosis (1, 41–43). This can be
expected to result in a “filtering” of mutated GC B cells in favor of
the less cross-reactive clonotypes. Subsequent optimization could
represent an Ag-driven process where the requirement for surviv-
ing B cells to competitively displace Ag from immune complexes
imposes an additional level of stringency.
In summary, results presented in this report suggest that, within
GCs, immune complexes play a major role in enhancement of the
memory B cell compartment. Further, this activity is specificity
restricted, demanding an identity at the level of epitope fine spec-
ificity of GC B cells and the Abs that constitute the immune com-
plex. Thus, in addition to clone autonomous Ab maturation within
GCs (18, 44), memory B cells also appear to be primarily gener-
ated in a “specificity autonomous” fashion. These findings may
have interesting implications for the relative extents of epitope-
specific memory B cells produced in immune responses to multi-
valent Ags. Finally, an extension of our studies on the regulation
of Ab specificity by immune complexes may also provide a further
insight into processes that restrict generation of autoreactive B
cells as a result of somatic mutations within GCs.
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